FDA advisory panel gives thumbs-up to CBD epilepsy treatment
A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market.A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don’t respond to other drugs.
The panel voted unanimously to recommend that the FDA approve Epidiolex after hearing presentations on the drug’s effectiveness and safety.
The recommendation doesn’t bind the agency to approving Epidiolex, but its recommendations carry serious weight.
The FDA has said it will issue a decision by late June.
(Click here to read the full story at Hemp Industry Daily.)357
- An FDA Advisory Panel Has Recommended Approval Of A New CBD-Based Drug For Epilepsywww.civilized.lifeApril 20, 2018
- Synthetic Pharmaceutical CBD Gets Approval from FDA Advisory Panelilmmj.comJune 19, 2018
- Synthetic Pharmaceutical CBD Gets Approval from FDA Advisory Panelnhmarijuana.comJune 19, 2018
- Los Angeles County Board of Supervisors Gives Thumbs Up To Nelson Hardiman Partner , Aaron Lachant.www.greenmarketreport.comJune 26, 2018